Czech Republic (CZ)

QOL After APBI (Multicatheter Brachytherapy) Versus WBI: 5-Year Results, Phase 3 GEC-ESTRO Trial (2018) Schaefer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, et al. Conference contribution The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: Case finding, screening and characteristics of eligible participants (2018) Marzetti E, Cesari M, Calvani R, Msihid J, Tosato M, Rodriguez-Manas L, Lattanzio F, et al. Journal article Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial (2018) Schaefer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott O, Kauer-Dorner D, et al. Journal article ESPEN guideline on clinical nutrition and hydration in geriatrics (2018) Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Goisser S, Hooper L, Kiesswetter E, et al. Journal article Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients (2018) Suttorp M, Metzler M, Shimada H, Bansal D, Gunes AM, Kalwak K, Sedlacek P, et al. Journal article Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial (2018) Suttorp M, Schulze P, Glauche I, Goehring G, Von Neuhoff N, Metzler M, Sedlacek P, et al. Journal article Heat-resistant action potentials require TTX-resistant sodium channels NaV1.8 and NaV1.9 (2018) Touska F, Turnquist B, Vlachova V, Reeh P, Leffler A, Zimmermann K Journal article Novel injectable gellan gum hydrogel composites incorporating Zn- and Sr-enriched bioactive glass microparticles: High-resolution X-ray microcomputed tomography, antibacterial and in vitro testing (2018) Douglas TEL, Dziadek M, Gorodzha S, Liskova J, Brackman G, Vanhoorne V, Vervaet C, et al. Journal article, Original article Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide Autogel/depot 120mg in the CLARINET open-label extension (2018) Pavel ME, Cwikla J, Wolin E, Phan A, Raderer M, Sedlackova E, Cadiot G, et al. Conference contribution Final Progression-Free Survival Analyses for Lanreotide Autogel/Depot 120 mg in Metastatic Enteropancreatic Neuroendocrine Tumors: The CLARINET Extension Study (2018) Wolin EM, Pavel ME, Cwikla JB, Phan AT, Raderer M, Sedlackova E, Cadiot G, et al. Conference contribution